Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (193)	8/9/2007 11:57:44 AM
From: tuck	Read Replies (2) \| Respond to of 285

Thanks for the notes. I will listen, but probably won't have much to add there (if I can find out anything re super Xigris, I'll post that). FWIW, I just sold some September calls against my position, reasoning that there's more IV premium in them than usual, and why not harvest it? It implies a possibility that the FDA would act before the PDUFA date by calling for an AC panel at the 11th hour, or, even more unlikely, rendering a decision before September expiration. I'll take that bet. If CRME is above $10 at expiration, I will happily buy those calls back for whatever they are going for. Cheers, Tuck